US regulators could approve the first new drug to treat Alzheimer’s in more than a decade, possibly paving the way for it to be used in the UK.

The Food and Drug Administration (FDA) is due to decide on Monday whether to approve Biogen’s aducanumab drug for use in the US.

Aducanumab targets amyloid – plaque that builds up in the brains of people with Alzheimer’s – helping to slow the onset of the condition.

It is the first treatment to target the cause of the disease, as existing ones only help to ease symptoms.

If approved, it could lead other pharmaceutical companies to create similar drugs and the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), to consider it for use in Britain.

Drugs company Biogen says that 1.5 million Americans would be eligible for the new drug, which is administered via infusion.

In the UK it could help the estimated 850,000 people living with the disease.

MPs have launched an investigation into the possible link between head injuries in sport and neurodegenerative diseases after campaigns by footballers and rugby players.

Related posts:

‘I don’t give a hoot’: Kurt Cobain’s self-drawn caricature sells for more than $281,000 Fed jolts market as it signals US rate hike could come ‘somewhat sooner’ ‘Our sweet, good boy’: Biden family pay tribute after death of pet dog Champ Around 2,000 evacuate as huge Oregon wildfire torches area larger than New York City ‘Hollywood Ripper’ sentenced to death for murder of two women Fury and Wilder weigh in at their heaviest for fight – as Brit sends message to The Undertaker Tyson Fury retains his WBC heavyweight title after knocking out Deontay Wilder in Las Vegas California oil spill: Closed beaches set to reopen after testing finds water free of toxins ‘I defended myself’: Teenager who shot three men on night of protests breaks down in court Olympic gold medallist says she was pepper-sprayed in racist attack Dolphin with prosthetic tail that starred in two films dies ‘Congratulations fellas!’: Biden makes video call to Ireland rugby team after All Blacks win